In addition to ATM, germline mutations in MRE11 has been shown to be predictive of radiotherapy response in bladder cancer [23, 24], while inherited defects in DSB repair genes NBS1 and Lig4 have been linked to fatal complications from low doses of radiotherapy [25–27]. This evidence concerns the gene MRE11 and urinary bladder cancer.